Gene · 9900
Papers2,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy and safety of Brivaracetam as adjunctive therapy in pediatric epilepsy: A systematic review and meta-analysis. | Neurol Sci | 2025 | 40319125 | PubTator, text mining | PubMed |
| Associations between fluid biomarkers and PET imaging ([ 11 C]UCB-J) of synaptic pathology in Alzheimer's disease. | bioRxiv | 2025 | 40236111 | PubTator, text mining | PubMed |
| Increase of Brivaracetam serum concentration with introduction of Cenobamate. | Front Pharmacol | 2025 | 40235536 | PubTator, text mining | PubMed |
| Fibre density and cross-section associate with hallmark pathology in early Alzheimer's disease. | Alzheimers Res Ther | 2025 | 40188035 | PubTator, text mining | PubMed |
| Generating synthetic brain PET images of synaptic density based on MR T1 images using deep learning. | EJNMMI Phys | 2025 | 40163154 | PubTator, text mining | PubMed |
| Editorial: Mechanisms of auditory development, maintenance, damage, and protection. | Front Mol Neurosci | 2025 | 40134466 | PubTator, text mining | PubMed |
| Are resting-state network alterations in late-life depression related to synaptic density? Findings of a combined 11C-UCB-J PET and fMRI study. | Cereb Cortex | 2025 | 40072885 | PubTator, text mining | PubMed |
| Correlative light and electron microscopy imaging of proteinaceous deposits in cell cultures and brain tissues. | Acta Neuropathol Commun | 2025 | 40057802 | PubTator, text mining | PubMed |
| Imaging Synaptic Density in Aging and Alzheimer Disease with [18F]SynVesT-1. | J Nucl Med | 2025 | 40049743 | PubTator, text mining | PubMed |
| The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study. | Transl Psychiatry | 2025 | 40025026 | PubTator, text mining | PubMed |
| Higher level of [3H]UCB-J binding in ApoE Ɛ4 allele carriers with Alzheimer disease. | Neurosci Lett | 2025 | 39900278 | PubTator, text mining | PubMed |
| Head-to-Head comparison of [18F]FDG, [18F]FMZ, and [18F]SynVesT-1 positron emission tomography imaging in patients with drug-resistant epilepsy. | Eur J Nucl Med Mol Imaging | 2025 | 39888422 | PubTator, text mining | PubMed |
| Exploring volatility transmission in Capesize freight contracts: Insights from energy and commodity markets. | PLoS One | 2025 | 39854473 | PubTator, text mining | PubMed |
| Control of Synaptotagmin-1 Trafficking by SV2A-Mechanism and Consequences for Presynaptic Function and Dysfunction. | J Neurochem | 2025 | 39853744 | PubTator, text mining | PubMed |
| A multicenter Phase II randomized, placebo-controlled single-blind trial with the SV2A ligand seletracetam in photosensitive epilepsy patients. | Epilepsy Behav | 2025 | 39827675 | PubTator, text mining | PubMed |
| Neuromuscular junction visualization in paraffin-embedded thyroarytenoid muscle sections: Expanding options beyond frozen section analysis. | Laryngoscope Investig Otolaryngol | 2025 | 39780862 | PubTator, text mining | PubMed |
| Longitudinal synaptic loss versus tau Braak staging in amnestic mild cognitive impairment. | Alzheimers Dement | 2025 | 39732507 | PubTator, text mining | PubMed |
| Preclinical validation and kinetic modelling of the SV2A PET ligand [18F]UCB-J in mice. | J Cereb Blood Flow Metab | 2025 | 39628318 | PubTator, text mining | PubMed |
| Presynaptic terminal integrity is associated with glucose metabolism in Parkinson's disease. | Eur J Nucl Med Mol Imaging | 2025 | 39572432 | PubTator, text mining | PubMed |
| Synaptic Density in Early Stages of Psychosis and Clinical High Risk. | JAMA Psychiatry | 2025 | 39535765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9900/papers?page=8